Showing 1 to 12 of 69 results
Dementia Tech Startups Attract Funding Amidst Rising Dementia Cases
The rising prevalence of dementia, affecting nearly 57 million people globally in 2021, is driving significant investment in "dementia tech" startups like Isaac Health and Rippl Care, which offer innovative diagnostic, therapeutic, and care management solutions.
Dementia Tech Startups Attract Funding Amidst Rising Dementia Cases
The rising prevalence of dementia, affecting nearly 57 million people globally in 2021, is driving significant investment in "dementia tech" startups like Isaac Health and Rippl Care, which offer innovative diagnostic, therapeutic, and care management solutions.
Progress
24% Bias Score
Greece to Launch Center of Excellence for Dementia
Greece is establishing a Center of Excellence for Dementia in West Attica, funded by the "Pancyprian Initiative '21," to improve diagnosis, prevention, treatment, and caregiver training, officially launching in October.
Greece to Launch Center of Excellence for Dementia
Greece is establishing a Center of Excellence for Dementia in West Attica, funded by the "Pancyprian Initiative '21," to improve diagnosis, prevention, treatment, and caregiver training, officially launching in October.
Progress
44% Bias Score
Home and Away Uses Dementia Storyline to Raise Awareness
Lynne McGranger, after 33 years playing Irene on Home and Away, is leaving the show; her character will be diagnosed with dementia to raise awareness and encourage early diagnosis, contrasting with typical sensationalized portrayals.
Home and Away Uses Dementia Storyline to Raise Awareness
Lynne McGranger, after 33 years playing Irene on Home and Away, is leaving the show; her character will be diagnosed with dementia to raise awareness and encourage early diagnosis, contrasting with typical sensationalized portrayals.
Progress
20% Bias Score
Dementia's Stigmatizing Label: A Call for Alternative Terminology
A speaker at a retirement village prompted a discussion about replacing the stigmatizing term "dementia" with less judgmental medical terms like "major neurocognitive disorder" or the newly proposed "acquired neurocognitive divergency", which mirrors the neurodiversity movement's inclusive language.
Dementia's Stigmatizing Label: A Call for Alternative Terminology
A speaker at a retirement village prompted a discussion about replacing the stigmatizing term "dementia" with less judgmental medical terms like "major neurocognitive disorder" or the newly proposed "acquired neurocognitive divergency", which mirrors the neurodiversity movement's inclusive language.
Progress
44% Bias Score
EMA Reverses Alzheimer's Drug Block, Approves Donanemab Under Strict Protocols
The European Medicines Agency (EMA) reversed its decision to block Donanemab, a new Alzheimer's treatment, approving it for early-stage patients with at most one copy of a specific gene under strict safety protocols after initially deeming the risks outweighed the benefits; Donanemab slows Alzheimer...
EMA Reverses Alzheimer's Drug Block, Approves Donanemab Under Strict Protocols
The European Medicines Agency (EMA) reversed its decision to block Donanemab, a new Alzheimer's treatment, approving it for early-stage patients with at most one copy of a specific gene under strict safety protocols after initially deeming the risks outweighed the benefits; Donanemab slows Alzheimer...
Progress
40% Bias Score
Donanemab Approved for Early-Stage Alzheimer's with Stricter Guidelines
Donanemab, a new Alzheimer's drug, received conditional approval in Europe, slowing disease progression by up to six months in early stages for patients with mild cognitive impairment and only one copy of the ApoE4 gene, but with risks of brain swelling and bleeding.
Donanemab Approved for Early-Stage Alzheimer's with Stricter Guidelines
Donanemab, a new Alzheimer's drug, received conditional approval in Europe, slowing disease progression by up to six months in early stages for patients with mild cognitive impairment and only one copy of the ApoE4 gene, but with risks of brain swelling and bleeding.
Progress
48% Bias Score
Mediterranean Diet Significantly Lowers Dementia Risk in APOE4 Gene Carriers
A 34-year study of 5,700 people found that a Mediterranean diet reduced dementia risk by at least 35% in those with two APOE4 genes, a major Alzheimer's risk factor; higher adherence further decreased risk, suggesting improved metabolic function as a key mechanism.
Mediterranean Diet Significantly Lowers Dementia Risk in APOE4 Gene Carriers
A 34-year study of 5,700 people found that a Mediterranean diet reduced dementia risk by at least 35% in those with two APOE4 genes, a major Alzheimer's risk factor; higher adherence further decreased risk, suggesting improved metabolic function as a key mechanism.
Progress
44% Bias Score
Music's Impact on Memory Recall: Implications for Alzheimer's Therapy
A study of 233 participants aged 18-76 found that energetic songs trigger joyful memories, while quieter songs evoke calmer, romantic, or sad memories; this finding has implications for Alzheimer's therapy.
Music's Impact on Memory Recall: Implications for Alzheimer's Therapy
A study of 233 participants aged 18-76 found that energetic songs trigger joyful memories, while quieter songs evoke calmer, romantic, or sad memories; this finding has implications for Alzheimer's therapy.
Progress
24% Bias Score
Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals
A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.
Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals
A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.
Progress
40% Bias Score
High-Intensity Caregiving in the U.S.: A Growing Crisis
A 2025 report reveals 44% of U.S. family caregivers face high-intensity situations, causing significant emotional and physical strain, particularly for women caring for spouses with chronic illnesses; research emphasizes the need for targeted support systems and policy changes to address this growin...
High-Intensity Caregiving in the U.S.: A Growing Crisis
A 2025 report reveals 44% of U.S. family caregivers face high-intensity situations, causing significant emotional and physical strain, particularly for women caring for spouses with chronic illnesses; research emphasizes the need for targeted support systems and policy changes to address this growin...
Progress
32% Bias Score
EMA Conditionally Approves Alzheimer's Drug Donanemab Under Strict Monitoring
The European Medicines Agency conditionally approved Eli Lilly's Donanemab for early-stage Alzheimer's patients with one or zero copies of a specific gene, reversing its initial rejection due to the risk of fatal brain swelling and bleeding, mirroring a similar approval process for Lecanemab.
EMA Conditionally Approves Alzheimer's Drug Donanemab Under Strict Monitoring
The European Medicines Agency conditionally approved Eli Lilly's Donanemab for early-stage Alzheimer's patients with one or zero copies of a specific gene, reversing its initial rejection due to the risk of fatal brain swelling and bleeding, mirroring a similar approval process for Lecanemab.
Progress
40% Bias Score
GLP-1 Drugs Show Promise in Reducing Dementia Risk for Type 2 Diabetes Patients
A study of 174,458 type 2 diabetes patients (2004-2024) found GLP-1 drugs reduced dementia risk by up to 25 percent compared to metformin, also lowering overall death rates; further research is needed.
GLP-1 Drugs Show Promise in Reducing Dementia Risk for Type 2 Diabetes Patients
A study of 174,458 type 2 diabetes patients (2004-2024) found GLP-1 drugs reduced dementia risk by up to 25 percent compared to metformin, also lowering overall death rates; further research is needed.
Progress
56% Bias Score
Showing 1 to 12 of 69 results